Jolien Heukelom - Publications

Affiliations: 
2019 University of Amsterdam, Amsterdam, Netherlands 

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Mulder SL, Heukelom J, McDonald BA, Van Dijk L, Wahid KA, Sanders K, Salzillo TC, Hemmati M, Schaefer A, Fuller CD. MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers. Cancers. 14. PMID 35454816 DOI: 10.3390/cancers14081909  0.623
2020 Franco P, Tesio V, Bertholet J, Gasnier A, Gonzalez Del Portillo E, Spalek M, Bibault JE, Borst G, Van Elmpt W, Thorwarth D, Mullaney L, Røe Redalen K, Dubois L, Chargari C, Perryck S, ... Heukelom J, et al. The role of alexithymia and empathy on radiation therapists' professional quality of life. Technical Innovations & Patient Support in Radiation Oncology. 15: 29-36. PMID 32904144 DOI: 10.1016/J.Tipsro.2020.07.001  0.643
2020 Franco P, Tesio V, Bertholet J, Gasnier A, Gonzalez Del Portillo E, Spalek M, Bibault JE, Borst G, Van Elmpt W, Thorwarth D, Mullaney L, Røe Redalen K, Dubois L, Chargari C, Perryck S, ... Heukelom J, et al. Professional quality of life and burnout amongst radiation oncologists: the impact of alexythymia and empathy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32417347 DOI: 10.1016/J.Radonc.2020.05.017  0.641
2019 Heukelom J, Kantor ME, Mohamed ASR, Elhalawani H, Kocak-Uzel E, Lin T, Yang J, Aristophanous M, Rasch CR, Fuller CD, Sonke JJ. Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 31431381 DOI: 10.1016/J.Radonc.2019.07.034  0.804
2019 Heukelom J, Navran A, Gouw ZAR, Tesselaar ME, Zuur CL, van Werkhoven E, Sonke JJ, Rasch CRN, Al-Mamgani A. Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort Analysis. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 161: 288-296. PMID 31060436 DOI: 10.1177/0194599819846073  0.585
2019 Heukelom J, Fuller CD. Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician. Seminars in Radiation Oncology. 29: 258-273. PMID 31027643 DOI: 10.1016/J.Semradonc.2019.02.008  0.706
2019 McCulloch MM, Lee C, Rosen BS, Kamp JD, Lockhart CM, Lee JY, Polan DF, Hawkin PG, Anderson CJR, Heukelom J, Sonke JJ, Fuller CD, Balter JM, Ten Haken RK, Eisbruch A, et al. Predictive models to determine clinically relevant deviations in delivered dose for head and neck cancer. Practical Radiation Oncology. PMID 30836190 DOI: 10.1016/J.Prro.2019.02.014  0.801
2018 Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, et al. Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Scientific Data. 5: 1. PMID 30482902 DOI: 10.1038/S41597-018-0002-5  0.645
2018 Grossberg AJ, Mohamed ASR, El Halawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, et al. Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Scientific Data. 5: 180173. PMID 30179230 DOI: 10.1038/Sdata.2018.173  0.687
2018 Heukelom J, Kantor M, Mohamed A, Elhalawani H, Kocak E, Lin T, Williamson R, Rasch C, Fuller C, Sonke J. The Difference Between Planned and Delivered Dose for Head and Neck Cancer, and the Consequences for Normal Tissue Toxicity Probability International Journal of Radiation Oncology*Biology*Physics. 102: e224-e225. DOI: 10.1016/J.Ijrobp.2018.07.770  0.811
2018 Rishi A, Latifi K, Zhang GG, Naghavi AO, Enderling H, Moros EG, Heukelom J, Mohamed ASR, Fuller CD, Harrison LB, Caudell JJ. CT-Based Nodal Radiomic Biomarkers Predictive of Patient Outcome in Head and Neck Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 100: 1360. DOI: 10.1016/J.Ijrobp.2017.12.140  0.623
2017 Heukelom J, Lamers E, Slooten E, van Werkhoven E, Rasch C, Sonke J. Redistributed versus homogenous radiotherapy dose for head and neck cancer; a treatment planning study Physics and Imaging in Radiation Oncology. 3: 17-20. DOI: 10.1016/J.Phro.2017.07.002  0.79
2017 Rishi A, Latifi K, Naghavi AO, Zhang GG, Enderling H, Moros EG, Heukelom J, Mohamed ASR, Fuller CD, Harrison LB, Caudell JJ. CT-Based Nodal Radiomic Features and Outcome in Head and Neck Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.2323  0.609
2017 Latifi K, Rishi A, Enderling H, Moros E, Heukelom J, Mohamed A, Fuller C, Harrison L, Caudell J. Mid-treatment Nodal Response is Associated With Outcome in Head and Neck Squamous Cell Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E683. DOI: 10.1016/J.Ijrobp.2017.06.2249  0.656
2017 Enderling H, Latifi K, Rishi A, Howard R, Moros E, Heukelom J, Mohamed A, Fuller C, Harrison L, Caudell J. Mathematical Model of Head and Neck Cancer Response to Predict Fractionation Schema for Robust Responses During Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: E656. DOI: 10.1016/J.Ijrobp.2017.06.2185  0.658
2016 Even AJ, Hamming-Vrieze O, van Elmpt W, Winnepenninckx VJ, Heukelom J, Tesselaar ME, Vogel WV, Hoeben A, Zegers CM, Vugts DJ, van Dongen GA, Bartelink H, Mottaghy FM, Hoebers F, Lambin P. Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach. Oncotarget. PMID 27965472 DOI: 10.18632/Oncotarget.13910  0.382
2016 de Ridder M, Gouw ZAR, Sonke JJ, Navran A, Jasperse B, Heukelom J, Tesselaar MET, Klop WMC, van den Brekel MWM, Al-Mamgani A. Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. 274: 1691-1700. PMID 27942891 DOI: 10.1007/S00405-016-4413-7  0.549
2016 Chamchod S, Fuller CD, Mohamed AS, Grossberg A, Messer JA, Heukelom J, Gunn GB, Kantor ME, Eichelberger H, Garden AS, Rosenthal DI. Quantitative body mass characterization before and after head and neck cancer radiotherapy: A challenge of height-weight formulae using computed tomography measurement. Oral Oncology. 61: 62-9. PMID 27688106 DOI: 10.1016/J.Oraloncology.2016.08.012  0.672
2016 Campbell SR, Mohamed AS, Heukelom J, Awan MJ, Garden AS, Gunn GB, Rosenthal DI, Fuller CD. Primary Tumor Regression Index: The Prognostic Value of Volumetric Image Guided Radiation Therapy for Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E363-E364. PMID 27674487 DOI: 10.1016/J.Ijrobp.2016.06.1544  0.781
2016 Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, Kantor ME, Hutcheson KA, Gunn GB, Garden AS, Frank S, Phan J, Beadle B, Skinner HD, Morrison WH, et al. Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma. Jama Oncology. PMID 26891703 DOI: 10.1001/Jamaoncol.2015.6339  0.626
2016 Heukelom J, Fuller C, Kantor M, Kauweloa K, Rasch C, Sonke J. PO-0906: NTCP differences between planned and delivered dose in treatment for head and neck cancer Radiotherapy and Oncology. 119: S436-S437. DOI: 10.1016/S0167-8140(16)32156-9  0.818
2016 Campbell S, Mohamed A, Heukelom J, Awan M, Garden A, Gunn G, Rosenthal D, Fuller C. Primary Tumor and Nodal Regression Rates: The Prognostic Value of Volumetric Image Guided Radiation Therapy for Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 94: 922. DOI: 10.1016/J.Ijrobp.2015.12.168  0.765
2016 Lewin T, Kim J, Latifi K, Poleszczuk J, Bull J, Byrne H, Torres-Roca J, Moros E, Gatenby R, Harrison L, Heukelom J, Mohamed A, Rosenthal D, Fuller C, Caudell J, et al. Proliferation Saturation Index Predicts Oropharyngeal Squamous Cell Cancer Gross Tumor Volume Reduction to Prospectively Identify Patients for Adaptive Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 94: 903. DOI: 10.1016/J.Ijrobp.2015.12.116  0.658
2015 Heukelom J, Lopez-Yurda M, Balm AJ, Wijers OB, Buter J, Gregor T, Wiggenraad R, de Boer JP, Tan IB, Verheij M, Sonke JJ, Rasch CR. Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer. Head & Neck. PMID 25728984 DOI: 10.1002/Hed.24023  0.791
2015 Chamchod S, Fuller C, Mohamed A, Grossberg A, Messer J, Heukelom J, Gunn G, Kantor M, Eichelberger H, Garden A, Rosenthal D. Body Mass Characterization Before and After Head and Neck Cancer Radiation Therapy: Analysis Using Quantitative Computed Tomography Measurement. International Journal of Radiation Oncology*Biology*Physics. 93: E316. DOI: 10.1016/J.Ijrobp.2015.07.1350  0.651
2013 Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T, Verheij M, van den Brekel M, Vogel W, Slevin N, Deutsch E, Sonke JJ, Lambin P, Rasch C. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. Bmc Cancer. 13: 84. PMID 23433435 DOI: 10.1186/1471-2407-13-84  0.807
2013 Heukelom J, Nichol K, Bartelink H, Hamming O, Lamers E, Rasch C, Verheij M, Sonke J. PO-0662: Planning according to plan: quality assurance in a randomized international multicenter phase II trial Radiotherapy and Oncology. 106: S254-S255. DOI: 10.1016/S0167-8140(15)32968-6  0.749
Show low-probability matches.